Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients (Q44301966)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients |
scientific article |
Statements
1 reference
Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients (English)
1 reference
Blennow K
1 reference
Almkvist O
1 reference
Nordberg A
1 reference
Stefanova E
1 reference
Hellström-Lindahl E
1 reference
1 February 2003
1 reference
1 reference
338
1 reference
2
1 reference
159-163
1 reference
Identifiers
1 reference
1 reference